Abstract
(Abstracted from Gynecol Oncol 2022;165:664–670) Adoptive cell therapy (ACT) is a form of immunotherapy that has shown promising results in hematologic malignancies and some solid tumors. In ACT, autologous immune cells are extracted, expanded, and stimulated or engineered for reinfusion alongside growth factors to augment in vivo anticancer activity.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
